PCV82 Simulation of Long-Term Clinical Benefits and Costs of Add-On Therapy with Aliskiren in Hypertensive Patients with Diabetic Nephropathy- A German Statutory Health Insurance Perspective
Nov 1, 2011, 00:00
10.1016/j.jval.2011.08.802
https://www.valueinhealthjournal.com/article/S1098-3015(11)02364-3/fulltext
Title :
PCV82 Simulation of Long-Term Clinical Benefits and Costs of Add-On Therapy with Aliskiren in Hypertensive Patients with Diabetic Nephropathy- A German Statutory Health Insurance Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)02364-3&doi=10.1016/j.jval.2011.08.802
First page :
A379
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
769